BRAIN Biotech AG
XETRA:BNN
BRAIN Biotech AG
XETRA:BNN
Price:
2.72 EUR
-2.16%
Updated:
May 7, 2024
BRAIN Biotech AG
Cash from Financing Activities
|
BRAIN Biotech AG
Cash from Financing Activities Peer Comparison
Comparables:
WCH
EVK
1COV
ACT
SY1
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
BRAIN Biotech AG
XETRA:BNN
|
Cash from Financing Activities
€574k
|
CAGR 3-Years
-65%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Wacker Chemie AG
XETRA:WCH
|
Cash from Financing Activities
-€688.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
|
|
Evonik Industries AG
XETRA:EVK
|
Cash from Financing Activities
-€823m
|
CAGR 3-Years
22%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-3%
|
|
|
Covestro AG
XETRA:1COV
|
Cash from Financing Activities
-€639m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
23%
|
CAGR 10-Years
N/A
|
|
|
AlzChem Group AG
XETRA:ACT
|
Cash from Financing Activities
-€49.2m
|
CAGR 3-Years
-61%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Symrise AG
XETRA:SY1
|
Cash from Financing Activities
-€264.2m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-7%
|
See Also
What is BRAIN Biotech AG's Cash from Financing Activities?
Cash from Financing Activities
574k
EUR
574k
EUR
Based on the financial report for Dec 31, 2023, BRAIN Biotech AG's Cash from Financing Activities amounts to 574k EUR.
What is BRAIN Biotech AG's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 3Y
-65%
-65%
Over the last year, the Cash from Financing Activities growth was 72%. The average annual Cash from Financing Activities growth rates for BRAIN Biotech AG have been -65% over the past three years .
You don't have any saved screeners yet
